We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AmpliPhi Signs Exclusive License With University of Leicester, UK

News   Oct 18, 2013

 
AmpliPhi Signs Exclusive License With University of Leicester, UK
 
 
 

RELATED ARTICLES

Broadly Acting Antibodies Found in Blood of Ebola Survivors

News

Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.

READ MORE

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

Immatics Enters into a Strategic Partnership with Genmab

News

Immatics and Genmab to combine proprietary technologies to create transformative bispecific therapies against novel, proprietary tumor targets.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE